PCMU
HALO icon

Paragon Capital Management (Utah)’s Halozyme HALO Stock Holding History

Paragon Capital Management (Utah)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,920
Closed -$1.27M – 81
2025
Q4 		$1.27M Buy
+18,920
New +$1.27M 0.98% 37

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paragon Capital Management (Utah)'s HALO Position: Q1 2026 in Review

Paragon Capital Management (Utah) sold out of Halozyme (HALO) in Q1 2026, closing a stake of 18,920 shares — an estimated $1.27M sold.

Paragon Capital Management (Utah) first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $1.27M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Paragon Capital Management (Utah) reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 18,920 Halozyme shares in Q1 2026, an estimated $1.27M.
  • Paragon Capital Management (Utah) first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
  • Paragon Capital Management (Utah)'s Halozyme position peaked at $1.27M in Q4 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Paragon Capital Management (Utah)'s 13F filing for Q1 2026, filed 17 Apr 2026.